Learn more about how NCATS will bridge translational science gaps to address the opioid crisis in the July 2018 NCATS Director's Message.
-
Research
-
- Funding & Notices
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Stem Cell Translation Laboratory
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- A Translational Approach to Addressing COVID-19
- Antiviral Program for Pandemics
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
- Multidisciplinary Machine-Assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey
- National COVID Cohort Collaborative (N3C)
- The Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (BGTC)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Functional Genomics Lab
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- About NCATS
- Center Overview
- Director's Corner
- 2012 Director's Messages
2012 Director's Messages Director's Messages
As NIH’s newest Center, NCATS is moving boldly toward establishing a strategic vision that will transform the translational process for the benefit of science and patients. We are establishing an organization that emphasizes innovation and deliverables and relies on the power of data to develop, demonstrate and disseminate improvements in translational science...
It is an exciting time for science. Today, we know so much about the molecular basis of disease and by pairing this knowledge with advances in technology and with expert partners, we can transform the translational research process into an efficient and collaborative enterprise...
Already, NCATS has become a hub of innovation for translational sciences. Since its creation in December 2011, the Center has launched several major research initiatives, cultivated promising strategic partnerships, and established a presence at NIH and in the community — all while standing up a brand new center...
Welcome to the National Center for Advancing Translational Sciences at the NIH. Our mission is to catalyze the generation of innovative methods and technologies that enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions...
Send FeedbackNCATS Director on NIH HEAL InitiativeTranslating Translation
Former NCATS Director Christopher P. Austin, M.D., defines, distinguishes and explores the promise of translation, translational research and translational science.
- Funding & Notices
-